2.5 ml of semaglutide 2mL Vial – Le Beau Visage Medical Spa 2.5 mg semaglutide in syringe:

Gastrointestinal adverse events Very common (10% or more): Diarrhea (35%), abdominal pain (21%), vomiting (21%), nausea (12%) Common (1% to 10%): Constipation, dyspepsia, gastrointestinal disorder, melena Very rare (less than 0.01%): Abdominal cramps [Ref] Nervous system Very common (10% or more): Headache (37%), dizziness (18%), paresthesia (12%) Common (1% to 10%): Hypertonia, vertigo, taste perversion Frequency not reported : Seizures (with or without pre-existing seizure activity), increase in seizure frequency and/or severity [Ref] Metabolic Very common (10% or more): Hypercalcemia (15%), hypervolemia (12%) Common (1% to 10%): Anorexia, hyperkalemia [Ref] There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients

Accessibility and Convenience: Evaluate how easy it is to schedule consultations, access prescriptions, and communicate with medical professionals

A week later, she had no new bruising at her injection sites

0.25 divided by 5 = 0.05 mL 0.05 times 100 = 5 units The math never changes